Advent international and warburg pincus complete acquisition of baxter's biopharma solutions business

Boston & new york--(business wire)--advent international (“advent”), one of the largest and most experienced global private equity investors, and warburg pincus, a leading global growth investor, today announced the completion of their previously announced acquisition of baxter international inc.'s (nyse:bax) biopharma solutions (bps) business. the business will now be a standalone contract development and manufacturing organization (cdmo) operating under the name simtra biopharma solutions (“s.
BAX Ratings Summary
BAX Quant Ranking